CoChat
Sign Up
Cited by 192Acute Ischemic Stroke ManagementLipoproteins and Cardiovascular HealthNeurological Disorders and Treatments

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

Martí-Fàbregas, Joan, Gomis, Meritxell, Arboix, Adrià, Aleu, Aitziber, Pagonabarraga, Javier, Belvís, Robert, Cocho, Dolores, Roquer, Jaume +5 more·2004·Stroke
DOI 10.1161/01.str.0000125863.93921.3f
Open this paper in CoChat — free account

Abstract

Background and Purpose— Statins may be beneficial for patients with acute ischemic stroke. We tested the hypothesis that patients pretreated with statins at the onset of stroke have less severe neurological effects and a better outcome. Methods— We prospectively included consecutive patients with ischemic stroke of <24-hour duration. We recorded demographic data, vascular risk factors, Oxfordshire Classification, National Institutes of Health Stroke Scale (NIHSS) score, admission blood glucose and body temperature, cause (Trial of Org 10172 in Acute Treatment [TOAST] criteria), neurological progression at day 3, previous statin treatment, and outcome at 3 months. We analyzed the data using univariate methods and a logistic regression with the dependent variable of good outcome (modified Rankin Scale [mRS] 0 to 1, Barthel Index [BI] 95 to 100). Results— We included 167 patients (mean age 70.7±12 years, 94 men). Thirty patients (18%) were using statins when admitted. In the statin group, the median NIHSS score was not significantly lower and the risk of progression was not significantly reduced. Favorable outcomes at 3 months were more frequent in the statin group (80% versus 61.3%, P =0.059 with the mRS; 76.7% versus 51.8%, P =0.015 with the BI). Predictors of favorable outcome with the BI were: NIHSS score at admission (OR: 0.72; CI: 0.65 to 0.80; P <0.0001), age (OR: 0.96; CI: 0.92 to 0.99; P =0.017), and statin group (OR: 5.55; CI: 1.42 to 17.8; P =0.012). Conclusions— Statins may provide benefits for the long-term functional outcome when administered before the onset of cerebral ischemia. However, randomized controlled trials will be required to evaluate the validity of our results.

Integrity signals

Registry

Crossref · 10.1161/01.str.0000125863.93921.3f

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Martí-Fàbregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvís, R., Cocho, D., Roquer, J., Rodríguez, A., García, M. D., Molina-Porcel, L., Díaz-Manera, J., & Martí-Vilalta, J.-L.
Affiliations
  • From Departments of Neurology, Hospital de la Santa Creu i Sant Pau (J.M.-F., A.A., J.P., R.B., D.C., M.D.G., L.M.-P., J.D.-M., J.-L.M.-V.), Hospital Nostra Senyora del Mar (M.G., J.R., A.R.), and Hospital del Sagrat Cor (A.A.), Barcelona, Spain.
  • Hospital de Sant Pau (ES)
ORCID
Venue
Stroke
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2004-05
Volume
35
Issue
5
Pages
1117-1121
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
DOI
10.1161/01.str.0000125863.93921.3f
OpenAlex
W2165231519
Cited by
192
References
40
Citations by year
2025: 4 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 16
FWCI
11.39
Type
journal article
Language
en
Open access
closed
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
Funders
Tel Aviv University
Topics
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
ischemic stroke, statins, functional outcome, neurological outcome, NIHSS score, modified Rankin Scale, Barthel Index, prognostic factors
MeSH terms
Aged, Brain Ischemia, Disability Evaluation, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Risk Factors, Severity of Illness Index, Logistic Models, Treatment Outcome, Disease Progression, Neuroprotective Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review